At the end of 2017, after receiving final regulatory approval for the merger, PotashCorp and Agrium combined into a new company called Nutrien (NTR). It began trading under a new ticker, NTR, on January 2, 2018, on the NYSE (New York Stock Exchange) and the TSX (Toronto Stock Exchange).
Ten Wall Street analysts are covering Nutrien. They have a consensus mean rating of 2.4 on the stock with an overall “buy” recommendation as of January 10, 2018.
Of those ten analysts, only one has a “strong buy” recommendation for the company for the next 12-month period, and five have a “buy” recommendation. Three analysts have a “hold” recommendation, and only one is recommending a “sell.” None of the analysts have given it a “strong sell” recommendation.
As of January 10, 2018, the current consensus median price target for Nutrien is $60, which would leave an upside of 16%.
TD Securities and Stifel Nicolaus are the most bullish on Nutrien, with price targets of $65 and $64, respectively. The Bank of America is the least bullish with a price target of $50. The Royal Bank of Canada, Cowen, and Raymond James Financial each have a $60 price target on the stock.
Next, let’s take a look at the ratings and price targets for Mosaic.